-
June 1, 2023 The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked OffThe largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant...
-
July 15, 2021 COVID-19 Pandemic Study of Ketamine Therapy Amplifies Antidepressant PotentialStudy authors even believe "treating serious mental illness may reduce adverse outcomes related to COVID-19."
-
March 23, 2021 Big Pharma Giant Merck Partners With Psychedelic Research Company NovamindPharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy...
